SGLT2i use is associated with an increased risk of DKA and UTI, but confers several favourable outcomes, notably preservation of renal function, reduced risk of developing heart failure and CKD, and of hospitalisation, despite a higher prevalence of heart failure, hypertension, IHD and CKD at baseline
While many users report significant weight loss and improved well-being, its crucial to be aware of the accompanying side effects, including diarrhea
Y.ChoiN
How to save an ischemic finger
The conserved substrate binding site of mitochondrial carriers
Please see Prescribing Information, including Medication Guide and Instructions for Use, at the link provided